wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26752780-BCC1B5CB-92E8-4C2B-A20D-D506E21EFAB5
Q26752780-BCC1B5CB-92E8-4C2B-A20D-D506E21EFAB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752780-BCC1B5CB-92E8-4C2B-A20D-D506E21EFAB5
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
P2860
Q26752780-BCC1B5CB-92E8-4C2B-A20D-D506E21EFAB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752780-BCC1B5CB-92E8-4C2B-A20D-D506E21EFAB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d752fbd52b62e130a0f06a1272886e6b5699de78
P2860
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer